InvestorsHub Logo
icon url

mskatiescarletohara

02/14/06 8:47 PM

#4238 RE: mmignot #4236

Thanks Mark, there aren't many cons associated with PPHM these days, Tarvacin appears to be hitting on many cylinders for multiple indications upcoming for 2006. Maybe they can get some solid financial backing, get results from cancer, HCV and start HIV/CMV this year and land a major partnership in 2007.

katie...